Okami Medical

Okami Medical

Private
Aliso Viejo, CaliforniaHealthcare & Life Scienceshttps://www.okamimedical.com

Last Round

Early Funding

Nov 19, 2025

Total Funding Raised

$56.7M

Momentum Score

50 /100

Company Overview

Okami Medical is a medical device company specializing in a peripheral embolization device that effectively occludes peripheral vessels to treat cardiovascular disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

vascular occlusion systemembolization deviceperipheral embolizationbraided occludercatheter-based deviceendovascular deviceinterventional radiology devicesperipheral vascular occlusionHDBRAIDmedical devicesMedTechmicrocatheterdelivery catheterhemorrhage controlFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Okami Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Okami Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 19, 2025
VC RoundOct 21, 2024
Seed RoundJan 9, 2024
Series DJun 24, 2020
Series BJul 25, 2017

Key People

Founding team and executive leadership

Drew Hykes

President And CEO

Executive Team

Rhonda Robb

President Chief Executive Officer

Executive Team

Okami Medical Investors

Notable investors and investment history

InvestorRounds
U.S. Venture PartnersSeries B, Early Funding, VC Round, Series D
Gilde HealthcareEarly Funding
Vensana CapitalEarly Funding, VC Round
Inceptus MedicalSeries B, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    Grew 16% QoQ from 43 to 50 employees.

  • Nov 19, 2025

    $45M raised in early funding round.

Okami Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Okami Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Okami Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersAliso Viejo, California
Employee Range50
Year Founded2011
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.